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We  tested  fecal  samples  from  150  healthy  children 
2–10 years of age who lived in rural Senegal and found the 
prevalence of Tropheryma whipplei was 44%. Unique geno-
types  were  associated  with  this  bacterium.  Our  findings 
suggest that T. whipplei is emerging as a highly prevalent 
pathogen in sub-Saharan Africa.
T
ropheryma whipplei is known mainly as the bacterial 
pathogen responsible for Whipple disease (1). Until re-
cently, it was thought to be a rare bacterium typically caus-
ing disease in white men (1). However, recent studies have 
shown 1%–11% prevalence of the bacterium in fecal sam-
ples from the healthy general adult population in Europe 
(2,3). T. whipplei also was viable in a fecal sample from a 
patient with Whipple disease (4). In addition, T. whipplei 
DNA has been detected in sewage and is more prevalent 
in fecal samples of sewer workers (12%–26%) than in the 
general population, supporting this environment as a likely 
ecologic niche (2,3). T. whipplei was highly prevalent in 
fecal samples of children 2–4 years of age in France who 
have gastroenteritis but was not detected in a control group 
of children of the same age who did not have diarrhea (5).
For these reasons, we speculated that if T. whipplei is 
transmitted through the fecal–oral route, it might be more 
prevalent in countries with poor sanitation, such as devel-
oping countries. Because no information is available about 
T. whipplei and Whipple disease in Africa, we conducted a 
study to assess the prevalence of T. whipplei in fecal sam-
ples from healthy children in Senegal, specifically in the 
villages of Dielmo and Ndiop (Figure 1).
The Study
In early April 2008, we sampled fecal specimens from 
150 healthy children (79 girls) 2 months–10 years of age 
(mean 3.5 years ± 2.5 years) living in 2 villages in Senegal 
(Ndiop, 77 children; Dielmo, 73 children) (6). These vil-
lages are included in the Dielmo project, initiated in 1990 
for long-term investigations of host–parasite associations 
in the entire village population, which was enrolled in a 
longitudinal prospective study (6,7). At the beginning of 
the current study, parents or legal guardians of all children 
gave individual informed consent. The national ethics com-
mittee of Senegal approved the project (6). Eight wells in 
the 2 villages (5 from Dielmo, 3 from Ndiop), which are the 
only sources of drinking water for the communities, also 
were sampled.
After collection, each fecal specimen was mixed with 
2.5 mL of absolute ethanol for storage and transportation 
to our laboratory at room temperature. On arrival, DNA 
was  extracted  by  using  the  BioRobot  MDx  workstation 
(QIAGEN, Valencia, CA, USA) in accordance with the 
manufacturer’s recommendations and protocols. T. whip-
plei quantitative PCR assays were performed as previously 
described (8). A case was defined as 2 positive quantita-
tive PCR results in assays targeting 2 different T. whipplei 
DNA sequences. T. whipplei genotyping using 4 variable 
sequences was performed by using samples from children 
with high bacterial loads, as previously reported (9).
Among the 150 healthy children, the prevalence of T. 
whipplei was 11% (2/18) in children <8 months of age, 37% 
(10/27) in children 8–24 months of age, and 44% (46/105) 
in children 2–10 years of age (Figure 1). None of the 8 wa-
ter wells sampled were positive for T. whipplei.
DISPATCHES
922  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 6, June 2009
Author affiliations: Université de la Méditerranée, Marseille, France 
(F. Fenollar, J.-F. Trape, H. Bassene, C. Sokhna, D. Raoult); Pôle 
de Maladies Infectieuses, Marseille (F. Fenollar, D. Raoult); and In-
stitut de Recherche pour le Développement, Dakar, Senegal (J.-F. 
Trape, H. Bassene, C. Sokhna, D. Raoult)
DOI: 10.3201/eid1506.090182
Figure 1. Location of Dielmo and Ndiop in Senegal, Africa. Plus-
symbol  lines  define  the  Senegal  frontiers. The  number  of  fecal 
samples positive for Tropheryma whipplei and number tested for 
children  in  each  age  group  was  as  follows:  Dielmo,  1/13  from 
children <8 months of age, 5/9 from children 8–24 months of age, 
and 19/54 from children 2–10 years; Ndiop, 1/5 for children <8 
months of age, 5/18 from children 8–24 months of age, and 27/51 
from children 2–10 years of age.Tropheryma whipplei, Senegal
A complete genotype was obtained from 18 healthy 
children (Figure 2). We found 10 new genotypes in 3 in-
dependent clusters, all of which were unique to Senegal. 
Four genotypes were detected only in Ndiop and 5 only in 
Dielmo. One genotype common to both villages was clas-
sified as epidemic to Ndiop.
Conclusions
In our study, 44% of children >2 years of age who live 
in rural Senegal carried T. whipplei. Our requirement for 
2 positive test results ruled out sample contamination, and 
the 4 different PCR amplifications and sequencing reac-
tions used for genotyping resulted in the discovery of novel 
sequences. This pathogen in Europe, Asia, and America 
has been reported at much lower prevalences than we found 
in Senegal (1–3,5). The unique genotypes we discovered 
in Senegal have not been demonstrated elsewhere through 
global DNA-based comparisons. This specific type of geo-
graphic distribution of genotypes also has been reported for 
Mycobacterium tuberculosis, for which researchers named 
genotypes using the same genotyping method (10). Clonal 
diffusion of a specific genotype within a single area favors 
a human-to-human transmission hypothesis, which the cir-
culating clones exemplified in Senegal.
In Senegal, children are contaminated with T. whipplei 
at an early age, and the high carriage rate we observed indi-
cates a potential public health problem. T. whipplei may be 
responsible for numerous undiagnosed infections, includ-
ing gastroenteritis, in Africa. The classic form of Whipple 
disease, characterized by histologic periodic acid-Schiff–
stained bacilli in infected small-bowel macrophages, may 
represent only 1 rare clinical variant of infection that T. 
whipplei can cause. The higher number of Whipple disease 
cases in white men may be related to a genetic factor or 
might reflect a large number of unrecognized cases in de-
veloping countries. However, T. whipplei also can cause 
localized infections, such as endocarditis, spondylodiscitis, 
meningoencephalitis, and uveitis (1). The bacterium also 
was detected in a child with pneumonia who resided in the 
United States (11).
Our study provides evidence that T. whipplei is com-
mon in fecal samples from children in Senegal and that local 
strains circulate in the 2 villages investigated. We suspect 
T. whipplei infection results directly from human-to-hu-
man transmission because water from all 8 village wells 
tested negative by PCR. T. whipplei is present throughout 
the world, and specific genotypes often are linked to geo-
graphic sources. We speculate that T. whipplei infection 
might be a major public health concern in sub-Saharan Af-
rica. Additional studies are needed to investigate the role of 
this extremely common emerging pathogen in developing 
countries.
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